1. 1. http://manipursacs.nic.in/history.html 2016.
2. 2. Saha MK, Chakrabarti S, Panda S, et al. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res 2000;111:37-9.
3. 3. Devi KhS, Brajachand N, Singh HL, et al. Co-infection by human immune deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. J Commun Dis 2005;37(1):73-7.
4. 4. Kalyesubula R, Kagimu M, Opio KC, et al. Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting. Afr Health Sci 2011;11:16-23.
5. 5. Mankhatithan W, Lueangniyomkul A, Manosuthin W. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitors based antiretroviral therapy and rifampicin containing anti-tuberculosis regimen. Southeast Asian J Trop Med Public Health 2011;42(3):651-8.